<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-235
Date of Submission: 2025-02-07

This report was submitted by a Nurse from Porter Inc Medical Center concerning patient ANON-PX-5744. The subject is a 19-year-old male with a significant medical history including atrial fibrillation, type 2 diabetes, migraines, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Warfarin (Anticoagulant) administered via the Oral route at a dosage of 132mg, initiated on 2024-12-18 for Thromboembolism prevention with the course ongoing.

On approximately 2025-02-04, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Pruritus, Dizziness. The Pruritus was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed author and advised peace. The current patient status regarding this symptom is 'Recovering'. The Dizziness was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed various and advised item. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 1 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Collection tough understand station interest where. Lead ready budget within lead dog.</data>
report_id: ADR-2025-235
report_date: '2025-02-07'
patient_details:
  patient_id: ANON-PX-5744
  gender: Male
  relevant_history:
  - atrial fibrillation
  - type 2 diabetes
  - migraines
  - hypertension
  age_at_reaction: 19
suspected_drugs:
- drug_name: Warfarin
  dosage: 132mg
  route_of_administration: Oral
  start_date: '2024-12-18'
  indication_for_use: Thromboembolism prevention
  drug_class: Anticoagulant
adverse_reactions:
- symptom_name: Pruritus
  onset_date: '2025-02-04'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed author and advised peace.
- symptom_name: Dizziness
  onset_date: '2025-02-04'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed various and advised item.
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 1
reporting_facility: Porter Inc Medical Center
reporter_type: Nurse
notes: Collection tough understand station interest where. Lead ready budget within
  lead dog.
